Supportive therapies for cancer chemotherapy patients and the role of the oncology nurse
- PMID: 9409062
- DOI: 10.1097/00002820-199712000-00004
Supportive therapies for cancer chemotherapy patients and the role of the oncology nurse
Abstract
Cancer chemotherapy often causes severe side effects, such as neutropenia, nausea and vomiting, and oral complications, which adversely affect patients' quality of life and may interfere with treatment success. A number of supportive therapies, such as colony stimulating-growth factors and antiemetics, have been developed to ameliorate these side effects, however, but often are underutilized. Oncology nurses, who serve as liaisons between oncologists and patients, can have a positive effect on patients' quality of life by educating them about potential side effects and the availability of supportive therapies, and by bringing patients' quality of life concerns and priorities to the attention of physicians. This article reviews the side effects of chemotherapy and the supportive therapies currently available to treat them and explores the role of oncology nurses as advocates for improved quality of life for chemotherapy patients.
Similar articles
-
[Perceptual gap between oncologists/oncology nurses and patients in the management and impact of chemotherapy/radiotherapy-induced nausea and vomiting: French results of the GAP survey].Bull Cancer. 2016 May;103(5):469-77. doi: 10.1016/j.bulcan.2016.02.011. Epub 2016 Mar 22. Bull Cancer. 2016. PMID: 27015797 French.
-
Protocols for managing chemotherapy-induced neutropenia in clinical oncology practices.Cancer Nurs. 2005 Jan-Feb;28(1):62-9. doi: 10.1097/00002820-200501000-00009. Cancer Nurs. 2005. PMID: 15681984
-
Filgrastim in patients with neutropenia: potential effects on quality of life.Drugs. 2002;62 Suppl 1:65-78. doi: 10.2165/00003495-200262001-00005. Drugs. 2002. PMID: 12479595 Review.
-
[Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].Przegl Lek. 2006;63(1):1-6. Przegl Lek. 2006. PMID: 16892890 Polish.
-
The benefits of haematopoietic growth factors in the management of gynaecological oncology.Eur J Gynaecol Oncol. 2004;25(2):133-44. Eur J Gynaecol Oncol. 2004. PMID: 15032269 Review.
Cited by
-
Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities.BMC Cancer. 2004 May 20;4:22. doi: 10.1186/1471-2407-4-22. BMC Cancer. 2004. PMID: 15153249 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources